GSK PLC GSK shares slid 1.10% to £13.95 Wednesday, on what proved to be an all-around poor trading session for the stock ...

Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s ...

Two 6-year-old girls from Pennsylvania have been tragically impacted by meningitis — one fatally, one left unable to walk or ...

(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease.

(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [RSV] vaccine Arexvy.

GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and ...

GlaxoSmithKline Consumer Nigeria Plc was incorporated in 1971. 46.4 per cent of the shares of the Company are held by Setfirst Limited and Smithkline Beecham Limited (both incorporated in the ...

GlaxoSmithKline Consumer Nigeria Plc has announced plans to shut down its operations in the country. This was disclosed in a press statement issued on Thursday and filed with the Nigerian Exchange ...

GlaxoSmithKline Plc (GSK), a British multinational drug maker and biotechnology company, has announced its intention to end operations in Nigeria. This was made known in a statement signed by the ...

Glaxosmithkline Plc has filed a 13D form with the SEC disclosing ownership of 39,660,487 shares of 23andMe Holding Co. Class A (ME). This represents 13.2% of the company.

GlaxoSmithKline PLC leaders and executives have shown their dedication by being a leading pharmaceutical company and research and development firm. GSK was named one of the 100 Best Companies for ...